Literature DB >> 25587120

Mitochondrial dysfunction in uremic cardiomyopathy.

David Taylor1, Sunil Bhandari2, Anne-Marie L Seymour3.   

Abstract

Uremic cardiomyopathy (UCM) is characterized by metabolic remodelling, compromised energetics, and loss of insulin-mediated cardioprotection, which result in unsustainable adaptations and heart failure. However, the role of mitochondria and the susceptibility of mitochondrial permeability transition pore (mPTP) formation in ischemia-reperfusion injury (IRI) in UCM are unknown. Using a rat model of chronic uremia, we investigated the oxidative capacity of mitochondria in UCM and their sensitivity to ischemia-reperfusion mimetic oxidant and calcium stressors to assess the susceptibility to mPTP formation. Uremic animals exhibited a 45% reduction in creatinine clearance (P < 0.01), and cardiac mitochondria demonstrated uncoupling with increased state 4 respiration. Following IRI, uremic mitochondria exhibited a 58% increase in state 4 respiration (P < 0.05), with an overall reduction in respiratory control ratio (P < 0.01). Cardiomyocytes from uremic animals displayed a 30% greater vulnerability to oxidant-induced cell death determined by FAD autofluorescence (P < 0.05) and reduced mitochondrial redox state on exposure to 200 μM H2O2 (P < 0.01). The susceptibility to calcium-induced permeability transition showed that maximum rates of depolarization were enhanced in uremia by 79%. These results demonstrate that mitochondrial respiration in the uremic heart is chronically uncoupled. Cardiomyocytes in UCM are characterized by a more oxidized mitochondrial network, with greater susceptibility to oxidant-induced cell death and enhanced vulnerability to calcium-induced mPTP formation. Collectively, these findings indicate that mitochondrial function is compromised in UCM with increased vulnerability to calcium and oxidant-induced stressors, which may underpin the enhanced predisposition to IRI in the uremic heart.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  chronic kidney disease; mitochondrial dysfunction; mitochondrial permeability transition pore; uremic cardiomyopathy

Mesh:

Substances:

Year:  2015        PMID: 25587120      PMCID: PMC4360036          DOI: 10.1152/ajprenal.00442.2014

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  68 in total

1.  Prolonged calcium transients and myocardial remodelling in early experimental uraemia.

Authors:  Aisling C McMahon; Stephen E Greenwald; Susan M Dodd; Martin J Hurst; Anthony E G Raine
Journal:  Nephrol Dial Transplant       Date:  2002-05       Impact factor: 5.992

2.  Simultaneous measurements of mitochondrial NADH and Ca(2+) during increased work in intact rat heart trabeculae.

Authors:  Rolf Brandes; Donald M Bers
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

Review 3.  Mitochondria in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  Cardiovasc Res       Date:  2010-07-28       Impact factor: 10.787

4.  Uremia aggravates left ventricular remodeling after myocardial infarction.

Authors:  Ralf Dikow; Ulrike Schmidt; Lars P Kihm; Matthias Schaier; Vedat Schwenger; Marie-Luise Gross; Hugo A Katus; Martin Zeier; Stefan E Hardt
Journal:  Am J Nephrol       Date:  2010-05-19       Impact factor: 3.754

Review 5.  Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury.

Authors:  Tetsuji Miura; Masaya Tanno
Journal:  Cardiovasc Drugs Ther       Date:  2010-06       Impact factor: 3.727

Review 6.  Uremic cardiomyopathy and insulin resistance: a critical role for akt?

Authors:  David Semple; Katie Smith; Sunil Bhandari; Anne-Marie L Seymour
Journal:  J Am Soc Nephrol       Date:  2010-07-15       Impact factor: 10.121

7.  Uremic cardiomyopathy is characterized by loss of the cardioprotective effects of insulin.

Authors:  David J Semple; Sunil Bhandari; Anne-Marie L Seymour
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-22

8.  Preconditioning protects the heart in a prolonged uremic condition.

Authors:  Gabriella F Kocsis; Márta Sárközy; Péter Bencsik; Márton Pipicz; Zoltán V Varga; János Pálóczi; Csaba Csonka; Péter Ferdinandy; Tamás Csont
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-09-14       Impact factor: 4.733

9.  Increased myocardial ischemia-reperfusion injury in renal failure involves cardiac adiponectin signal deficiency.

Authors:  Yanbin Song; Qiujun Yu; Junyi Zhang; Weidong Huang; Yi Liu; Haifeng Pei; Jingyi Liu; Lu Sun; Lu Yang; Congye Li; Yan Li; Fuyang Zhang; Yan Qu; Ling Tao
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-03-04       Impact factor: 4.310

10.  Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat.

Authors:  David Kennedy; Eiad Omran; Sankaridrug M Periyasamy; Jalaa Nadoor; Anumeet Priyadarshi; James C Willey; Deepak Malhotra; Zijian Xie; Joseph I Shapiro
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  16 in total

Review 1.  Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.

Authors:  Xiaoliang Wang; Jiang Liu; Christopher A Drummond; Joseph I Shapiro
Journal:  Expert Opin Ther Targets       Date:  2017-04-03       Impact factor: 6.902

Review 2.  Cardiac metabolic remodelling in chronic kidney disease.

Authors:  Nikayla Patel; Muhammad Magdi Yaqoob; Dunja Aksentijevic
Journal:  Nat Rev Nephrol       Date:  2022-05-30       Impact factor: 42.439

3.  Increased level of free-circulating MtDNA in maintenance hemodialysis patients: Possible role in systemic inflammation.

Authors:  Xiao-Yi Zhong; Yi Guo; Zhen Fan
Journal:  J Clin Lab Anal       Date:  2022-06-16       Impact factor: 3.124

4.  Myocardial bioenergetic abnormalities in experimental uremia.

Authors:  Alistair Ms Chesser; Steven M Harwood; Martin J Raftery; Muhammad M Yaqoob
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-05-24

Review 5.  New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease.

Authors:  José Pedraza-Chaverri; Laura G Sánchez-Lozada; Horacio Osorio-Alonso; Edilia Tapia; Alexandra Scholze
Journal:  Oxid Med Cell Longev       Date:  2016-06-27       Impact factor: 6.543

6.  Real-World Impact of Cardiovascular Disease and Anemia on Quality of Life and Productivity in Patients with Non-Dialysis-Dependent Chronic Kidney Disease.

Authors:  Adrian Covic; James Jackson; Anna Hadfield; James Pike; Dimitrie Siriopol
Journal:  Adv Ther       Date:  2017-06-03       Impact factor: 3.845

7.  Effect of parathyroid hormone-related protein on intracellular calcium ion and cyclic adenosine monophosphate concentrations in cardiac fibroblasts.

Authors:  Ping Zhou; Qiong Xiao; Zhao-Ting Su; Lin Zhu; Fang-Xia Jin; Xuan-Yi Du
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

Review 8.  Mechanisms and Modulation of Oxidative/Nitrative Stress in Type 4 Cardio-Renal Syndrome and Renal Sarcopenia.

Authors:  Márta Sárközy; Zsuzsanna Z A Kovács; Mónika G Kovács; Renáta Gáspár; Gergő Szűcs; László Dux
Journal:  Front Physiol       Date:  2018-11-26       Impact factor: 4.566

9.  Impact of Intravenous Iron on Oxidative Stress and Mitochondrial Function in Experimental Chronic Kidney Disease.

Authors:  Faisal Nuhu; Anne-Marie Seymour; Sunil Bhandari
Journal:  Antioxidants (Basel)       Date:  2019-10-21

Review 10.  Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human Pathology.

Authors:  Tim D Hewitson; Stephen G Holt; Edward R Smith
Journal:  Front Immunol       Date:  2015-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.